you are here:

RPG Life Sciences Ltd.

BSE: 532983 | NSE: RPGLIFE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE105J01010 | SECTOR: Pharmaceuticals

BSE Live

Dec 04, 16:00
371.00 -0.10 (-0.03%)
Volume
AVERAGE VOLUME
5-Day
4,186
10-Day
4,839
30-Day
3,862
846
  • Prev. Close

    371.10

  • Open Price

    378.00

  • Bid Price (Qty.)

    369.10 (100)

  • Offer Price (Qty.)

    378.50 (25)

NSE Live

Dec 04, 15:53
369.50 -3.85 (-1.03%)
Volume
AVERAGE VOLUME
5-Day
49,406
10-Day
53,789
30-Day
43,166
57,393
  • Prev. Close

    373.35

  • Open Price

    376.00

  • Bid Price (Qty.)

    369.50 (3950)

  • Offer Price (Qty.)

    0.00 (0)

Company History - RPG Life Sciences
2009
 
 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has
 been appointed as Controller - Legal & Company Secretary and
 Compliance Officer of the Company with effect from January 08, 2009.
 
 
 2010
 
 - Mr. Ajit Singh Chouhan, presently a Director of the Company has
 been appointed as Managing Director of the Company.
 
 - Mr. Sachin Raole, General Manager Finance has been designated as
 Chief Financial Officer (CFO) of the Company.
 
 
 2011
 
 - RPG Life Sciences launches dialysis deferring drug.
 
 - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company
 Secretary and Compliance Officer of the Company.
 
 2012
 
 -Board has recommended an equity dividend of Rs. 0.80 per share
 (10%).
 
 
 2013
 
 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi
 Mumbai API facility.
 
 -RPG Life Sciences bagged Asias Best Employer Brand Awards 2013 in
 Singapore.
 
 2014
 
 -Board has recommended a total dividend of Rs. 2.00 per share (25%)
 for the year 2014.
 
 2015
 -RPG Life Plans Skincare Foray
 
 2016
 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic
 Industry
 -RPG Life gains over 14 pct on getting EUGMP certification
 -RPG Life Sciences - RPG Life Sciences to expand its formulations
 business